Sarepta shares briefly leap 80% after FDA approves drug By: Top News and Analysis (pro) September 19, 2016 at 10:29 AM EDT Shares of Sarepta Therapeutics briefly surged more than 80 percent after the FDA approved its muscular dystrophy drug. Read More >>